FDA panel backs infant doses for kids' Tylenol

May 18, 2011

(AP) -- Federal health experts say dosing instructions for children younger than 2 years old should be added to Children's Tylenol and similar products containing acetaminophen, the popular pain reliever and fever reducer.

A panel of advisers voted 21-0 in favor of adding doses for babies and toddlers to over-the-counter acetaminophen formulas. The FDA has convened a two-day meeting to consider changes that will make the formulas safer and easier to use. The products under discussion include Johnson & Johnson's Children and Infants' Tylenol, Novartis' Triaminic and other brands.

These products have never contained dosing information for children under 2 to encourage parents to seek medical attention for sick infants.

But the FDA's panel said the lack of information contributes to confusion and can cause accidental overdose.


Related Stories

Recommended for you

Universal flu vaccine designed by scientists

September 30, 2016

An international team of scientists have designed a new generation of universal flu vaccines to protect against future global pandemics that could kill millions.


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.